Grup d’Estudi del Dany Multiorgànic

Aguilar del Rey J., Jodar Gimeno E., Branas Baztan F., Gomez Alonso C., Gonzalez Lama Y., Malouf Sierra J., Borrego R.S., Segura de la Morena J., Suarez Perez J.A., Valdes y Llorca C. (2020) Is vitamin-D supplementation not useful in patients at risk of fractures and falls?. GYNECOL ENDOCRINOL, 36 (2), 93-95.

IF: 2,260

Antón-Vázquez V, Farré EG, Cortes C, Hausmann JS, Corominas H. Adult-Onset Autoinflammatory Syndromes. J CLIN RHEUMATOL. 2020 Jun;26(4):160-163. doi: 10.1097/RHU.0000000000000956.

IF: 3,517

Atienza-Mateo B., Martin-Varillas J.L., Grana J., Espinosa G., Moriano C., Perez-Sandoval T., Garcia-Armario M.D., Castellvi I., Roman-Ivorra J.A., Olive A., Ybanez A., Martinez-Ferrer A., Narvaez J., Romero-Yuste S., Ojeda S., Ros I., Loricera J., Calvo-Rio V., Castaneda S., Gonzalez-Gay M.A., Blanco R. (2020) Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice. CLIN EXP RHEUMATOL, 38 (5), 69-75.

IF: 4,473

Azuaga A.B., Frade-Sosa B., Laiz A., Estrada P., Prior-Espanol A., Horcada L., Polino L., Moreno M., Moragues C., Urruticoechea-Arana A., Sellas A., Tandaipan J.L., Torrente-Segarra V., Garcia-Miguel J., Ros I., Ordonez S., Moya P., Reina D., Mateo-Soria L., Fito C., Beltran E., Pujol M., Cuervo A.M., Canete J.D., Ramirez J. (2020) Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study. CLIN RHEUMATOL, 39 (10), 2963-2971.

IF: 2,980

Benito N, Filella D, Mateo J, Fortuna AM, Gutierrez-Alliende JE, Hernandez N, Gimenez AM, Pomar V, Castellvi I, Corominas H, Casademont J, Domingo P. Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With COVID-19. FRONT MED (LAUSANNE). 2020 Aug 25;7:557. doi: 10.3389/fmed.2020.00557. PMID: 32984388; PMCID: PMC7477312.

IF: 5,091

Castellvi I., Elhai M., Bruni C., Airo P., Jordan S., Beretta L., Codullo V., Montecuco C.M., Bokarewa M., Iannonne F., Balbir A., Hsu V.M., Distler O., Matucci-Cerinic M., Allanore Y. (2020) Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience. SEMIN ARTHRITIS RHEU, 50 (6), 1489-1493.

IF: 5,532

Castellvi I., Simeon C.P., Sarmiento M., Casademont J., Corominas H., Fonollosa V. (2020) Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers. PLOS ONE, 15 (12 December), -.

IF: 3,240

Corominas H, Castellví I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Millán AM, Quijada MÁ, Puig M, Casademont J, Domingo P. Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort. CLIN IMMUNOL. 2020 Nov 12;223:108631. doi: 10.1016/j.clim.2020.108631. Epub ahead of print. PMID: 33189888; PMCID: PMC7658611.

IF: 3,969

Corominas H., de Agustin J. (2020) Ultrasound and elastography in Sjögren's syndrome Ecografía y elastografía en el diagnóstico de síndrome de Sjögren. MED CLIN-BARCELONA, 155 (6), 254-255.

IF: 1,725

Diaz-Torne C., Urruticoechea-Arana A., Ivorra-Cortes J., Diaz S., Dilla T., Sacristan J.A., Inciarte-Mundo J., Comellas M., Prades M., Lizan L. (2020) What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis. ADV THER, 37 (4), 1479-1495.

IF: 3,845

Diez-Manglano, J; Perez, SID; Fenoll, RG; Sanchez, LA; Formiga, F; Galvan, VG; Duenas, C; Roca, B; Diaz, CE; Vales, EC; UDMIVI Study Researchers (Torres O) Palliative Sedation in Patients Hospitalized in Internal Medicine Departments. J PAIN SYMPTOM MANAG: Volume 59, ISSUE 2, P302-309, February 01, 2020. DOI:https://doi.org/10.1016/j.jpainsymman.2019.10.013.

IF: 3,612

Díez-Manglano J; Sánchez Muñoz LA; García Fenoll R; Freire E; Plaza Canteli S; Machín Lázaro JM; Dueñas Gutiérrez C; Castiella Herrero J; de Isasmendi Pérez SI; Carneiro AH; Abad Requejo P; Torres Bonafonte O. Guía de práctica clínica de consenso sobre buenas prácticas en los cuidados al final de la vida de las Sociedades Española y Portuguesa de Medicina Interna. REV CLIN ESP. 2020 Jun 10:S0014-2565 (20) 30124-7. doi: 10.1016/j.rce.2020.04.014.

IF: 1,556

Domingo P., Mur I., Pomar V., Corominas H., Casademont J., de Benito N. (2020) The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19). EBIOMEDICINE, 58 (), -.

IF: 8,143

Frade-Sosa B., Narvaez J., Salman-Monte T.C., Castellanos-Moreira R., Ortiz-Santamaria V., Torrente-Segarra V., Castellvi I., Magallares B., Reina D., Minguez S., Salles M., Manrique de Lara M.G., Ordonez S., Riera E., Schur P.H., Gomez-Puerta J.A., on behalf the CAPICAT-MAS Study Group (2020) A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. LUPUS, 29 (10), 1216-1226.

IF: 2,911

Gonzalez-Serna D., Ochoa E., Lopez-Isac E., Julia A., Degenhardt F., Ortego-Centeno N., Radstake T.R.D.J., Franke A., Marsal S., Mayes M.D., Martin J., Marquez A., Assassi S., Zhou X., Tan F.K., Arnett F.C., Reveille J.D., Gorlova O., Chen W.V., Ying J., Gregersen P.K., Lee A.T., Voskuyl A.E., de Vries-Bouwstra J., Magro-Checa C., Broen J., Koeleman B.P.C., Simeon C.P., Fonollosa V., Guillen A., Carreira P., Castellvi I., Gonzalez-Gay M.A., Rios R., Callejas-Rubio J.L., Vargas-Hitos J.A., Garcia-Portales R., Camps M.T., Fernandez-Nebro A., Gonzalez-Escribano M.F., Garcia-Hernandez F.J., Castillo M.J., Aguirre M.A., Gomez-Gracia I., Rodriguez-Rodriguez L., Fernandez-Gutierrez B., de la Pena P.G., Vicente E., Andreu J.L., Fernandezde Castro M., Lopez-Longo F.J., Martinez L., Espinosa G., Tolosa C., Pros A., Rodriguez-Carballeira M., Narvaez F.J., Rubio-Rivas M., Ortiz-Santamaria V., Madronero A.B., Diaz B., Trapiella L., Sousa A., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Diaz-Gonzalez F., Hernandez V., Beltran E., Roman-Ivorra J.A., Grau E., Alegre-Sancho J.J., Blanco-Garcia F.J., Oreiro N., Freire M., Balsa A., Ortiz A.M., Hunzelmann N., Riemekasten G., Distler J.H.W., Witte T., Airo P., Beretta L., Santaniello A., Bellocchi C., Lunardi C., Moroncini G., Gabrielli A. (2020) A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease. SCI REP-UK, 10 (1), -.

IF: 4,379

Guisado-Alonso D, Edo MC, Estrada Alarcón PV, García-Sánchez SM, Font MÀ, Mena Romo L, Marrero-González P, Mengual JJ, Castrillo L, Montull C, Corominas H, Gómez-Choco M. Progression of Large Vessel Disease in Patients With Giant Cell Arteritis-Associated Ischemic Stroke: The Role of Vascular Imaging: A Case Series. J CLIN RHEUMATOL. 2020 Jul 23. doi: 10.1097/RHU.0000000000001498.

IF: 3,517

Lobo-Prat D., Corominas H., Pomar V. (2020) Suitability of serology tests for the diagnosis of Lyme disease. Single center urban cohort Idoneidad del análisis serológico de la enfermedad de Lyme en una cohorte urbana. MED CLIN-BARCELONA, (), -.

IF: 1,725

Miller P.D., Pannacciulli N., Malouf-Sierra J., Singer A., Czerwinski E., Bone H.G., Wang C., Huang S., Chines A., Lems W., Brown J.P. (2020) Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates. OSTEOPOROSIS INT, 31 (1), 181-191.

IF: 4,507

Moya Alvarado P., de Agustin de Oro J.J., Aparicio Espinar M., Armengol Perez E., Busquets Perez N., Carmona L., Casado Burgos E., Clavaguera Poch T., Cuervo Aguilera A., De Miguel Mendieta E., Estrada Alarcon P., Garcia Casares E., Holgado Perez S., Magallares Lopez B., Martinez Morillo M., Mateo Soria L., Moragues Pastor C., Moreno Martinez-Losa M., Ponce Fernandez A., Pujol Busquets M., Ramirez Garcia J., Reina Sanz D., Salles Lizarzaburu M., Santo Panero P., Sirvent Alierta E., Valls Roc M., Corominas Macias H. (2020) Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists. RHEUMATOL INT, (), -.

IF: 2,631

Moya P, Castellví I, Magallares B, Millan M, Wilson N, Corominas H. Healing of Mucocutaneous Lesions With Apremilast in Behçet Disease. J CLIN RHEUMATOL. 2020 Aug;26(5):e132.

IF: 3,517

Novella-Navarro M., Cabrera-Alarcon J.L., Diaz-Torne C., Aramburu-Munoz F., Janta I., Ortega de la O M.C., Prada-Ojeda A., Sala-Icardo L., Urruticoechea-Arana A., Garcia de la Pena Lefebvre P., Calvo-Aranda E. (2020) A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3. RHEUMATOL INT, 40 (7), 1081-1087.

IF: 2,631

Riancho-Zarrabeitia L., Martinez-Taboada V., Rua-Figueroa I., Alonso F., Galindo-Izquierdo M., Ovalles J., Olive-Marques A., Fernandez-Nebro A., Calvo-Alen J., Menor-Almagro R., Tomero-Muriel E., Uriarte-Isacelaya E., Botenau A., Andres M., Freire-Gonzalez M., Santos Soler G., Ruiz-Lucea E., Ibanez-Barcelo M., Castellvi I., Galisteo C., Quevedo Vila V., Raya E., Narvaez-Garcia J., Exposito L., Hernandez-Beriain J.A., Horcada L., Aurrecoechea E., Pego-Reigosa J.M. (2020) Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. LUPUS, 29 (12), 1556-1565.

IF: 2,911

Robles-Perez A., Dorca J., Castellvi I., Nolla J.M., Molina-Molina M., Narvaez J. (2020) Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data. RHEUMATOL INT, 40 (5), 719-726.

IF: 2,631

Romero-Bueno F., Diaz del Campo P., Trallero-Araguas E., Ruiz-Rodriguez J.C., Castellvi I., Rodriguez-Nieto M.J., Martinez-Becerra M.J., Sanchez-Pernaute O., Pinal-Fernandez I., Solanich X., Gono T., Gonzalez-Gay M.A., Plana M.N., Selva-O'Callaghan A. (2020) Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. SEMIN ARTHRITIS RHEU, 50 (4), 776-790.

IF: 5,532

Salman-Monte T.C., Sanchez-Piedra C., Fernandez Castro M., Andreu J.L., Martinez Taboada V., Olive A., Rosas J., Menor R., Rodriguez B., Garcia Aparicio A., Lopez Longo F.J., Manrique-Arija S., Garcia Vadillo J.A., Gil Barato S., Lopez-Gonzalez R., Galisteo C., Gonzalez Martin J., Ruiz Lucea E., Erausquin C., Melchor S., Moreira B., Raya E., Pego-Reigosa J.M., Cid N., Judez E., Moriano C., Narvaez F.J., Corominas H., Garcia Magallon B., Guillen Astete C., Castellvi I., Bohorquez C., Loricera J., Belzunegui J., Illera O., Torrente-Segarra V. (2020) Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. RHEUMATOL INT, 40 (8), 1259-1265.

IF: 2,631

Suarez-Calvet X., Alonso-Perez J., Castellvi I., Carrasco-Rozas A., Fernandez-Simon E., Zamora C., Martinez-Martinez L., Alonso-Jimenez A., Rojas-Garcia R., Turon J., Querol L., de Luna N., Milena-Millan A., Corominas H., Castillo D., Cortes-Vicente E., Illa I., Gallardo E., Diaz-Manera J. (2020) Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis. NEUROL-NEUROIMMUNOL, 7 (3), -.

IF: 8,485

Vela P., Sanchez-Piedra C., Perez-Garcia C., Castro-Villegas M.C., Freire M., Mateo L., Diaz-Torne C., Bohorquez C., Blanco-Madrigal J.M., Ros-Vilamajo I., Gomez S., Cano R., Sanchez-Alonso F., Diaz-Gonzalez F., Gomez-Reino J.J. (2020) Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: Data from the BIOBADASER III register. ARTHRITIS RES THER, 22 (1), 143-.

IF: 5,156

Vinyé Bausà M, Bausà Peris R, Corominas H. Cross-reactions between rheumatoid factor and IgM SARS-CoV-2. MED CLIN (ENGL ED). 2020 Nov 13;155(9):417-418. doi:10.1016/j.medcle.2020.07.006.

IF: 1,725

Zegarra-Mondragon S., Lopez-Gonzalez R., Martin-Martinez M.A., Garcia-Gomez C., Sanchez-Alonso F., Gonzalez-Juanatey C., Arija S.M., Hernan G.B., Pardo S.M., Escribano A.R., Garcia E.P., Frias E.D., Redondo J.R., Sanchez M.D., Cambron A.B.R., Ramos M.J.M., Montero S.A.R., Marco M.T.N., Valle M.M., Gonzalez J.G., Corral J.B., Llorca J., Castaneda S., Gonzalez-Gay M.A., de Rabago E.G., Morales E.A.B., Carlos Fernandez Lopez J., Villar N.O., Sandoval A.A., Blanco Garcia F.J., de Miquel C.A., Gonzalez Fernandez M.J., Codina R.H., Yoldi B., Ramentol M., Avila G., Barril S.M., Quesada E., Steiner M., Munoz S., Cobo T., Gamero F., Toron J.G., Espino P., Ros I., Ibanez M., Murillo C., Molina J.T., Sanmarti R., Berman H., Cabrera S., Ruiz V., Paton O.F., Gutierrez B.F., Abasolo L., Pina J.M., Canals D.F., Nolla J.M., Arias M.G., Uriarte M., Garcia Vadillo J.A., de Vicuna R.G., Nebro A.F., Lopez M.A.B., Urena I., Irigoyen M.V., Cagigal V.C., Garrido D.P., Garcia Aparicio A.M., Gomez R.B., Bautista P.G., Sanz A.H., Manero F.J., Zorzo F.J., Ubeda E.G., Gracia J.M., Audera C.B., Medrano M., Pecondon A., Erausquin C., Ojeda S., Quevedo J.C., Francisco F., Lozano C.R., Lopez Longo F.J., Gerona D., Fernandez C.G., Monteagudo I., del Pino J., Gonzalez M.D.S., Corrales A., Peiro M.E., Senabre J.M., Rosas J.C., Rotes I., Moreno E., Erra A., Grado D., Calvo J., Rueda A., Moller I., Rodriguez I., Barbadillo C., Raya E., Morales P., Nieto A., Jimenez I., Magro C., Exposito S.R., Nievas G.S., Navarro E.J., Fernandez M.S., Garcia Morales M.A., Bastero I.L., Consuegra G.G., Palmou N., Pujol M., Alonso E.R., Salvador G., Alvarez B.G., Cantabrana A., Bustabad S., Munoz A., Jimenez L.M., Hernandez T.G., Gonzalez Polo F.J., Almagro R.M., Moreno J.M., Serret E.G., Barroso C.L., Mendez L.C., Carballido C.F., del Castillo P.M., Naredo E., Valenciano A.C., Villa C.M., Turrion A., Sanchez J., Galindo M., Collantes E., Ruiz D., Font P., Bonilla G., Meseguer A.L., Moreno Martinez M.J., Beteta Fernandez M.D., Linares L.F., Gonzalez Gomez M.L., Rivera N.A., Berrizbeitia O.F., Garcia Vivar M.L., Riera M., Leon Y.M., Maymo J., Amirall M., Escolano S.I., Serrano S.S., Lis Bona M.P., Fiter J., Melon J.F., Espadaler L., Maiz O., Belzunegui J., Diaz C., Valls R., Castellvi I., Bonet M., Ruzafa E.M., Alen J.C., Sandoval T.P., Evrard E.R., Godo J.R., Espartero C.F., Navarro Blasco F.J., Antonio Gonzalez J., Miranda-Filloy J.A. (2020) Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: Results of the CARMA study. CLIN EXP RHEUMATOL, 38 (4), 662-669.

IF: 4,473